Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranibizumab in Residual Diabetic Macular Edema Following Previous Intravitreal Bevacizumab Therapy

NCT01253694 is registered in ClinicalTrials.gov with New England Retina Associates as lead sponsor.

NCT NCT01253694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01253694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranibizumab in Residual Diabetic Macular Edema Following Previous Intravitreal Bevacizumab Therapy
Lead sponsor
New England Retina Associates
Phase
Phase 2
Overall status
Withdrawn
Start date
March 31, 2011
Completion date
July 31, 2012
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema